Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Sold by Assetmark Inc.
Assetmark Inc. reduced its position in Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) by 7.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 111,588 shares of the biopharmaceutical company’s stock after selling 8,499 shares during the quarter. Assetmark […]
Assetmark Inc. reduced its position in Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) by 7.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 111,588 shares of the biopharmaceutical company’s stock after selling 8,499 shares during the quarter. Assetmark […]
